Back to search

United States· US:65841-825_99ca3856-ca2b-4a2d-b1a1-bd70f8f740b4

glyburide and metformin hydrochloride

A medicinal product containing glyburide; metformin hydrochloride, registered in United States by Zydus Lifesciences Limited.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedglyburide and metformin hydrochlorideATC—REGISTER NO.US:65841-825_99ca3856…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GLYBURIDE; METFORMIN HYDROCHLORIDE
Manufacturer
Zydus Lifesciences Limited
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    65841-825-01
  • ndc11
    65841-825-05
  • ndc11
    65841-825-06
  • ndc11
    65841-825-10
  • ndc11
    65841-825-16
  • ndc11
    65841-825-77

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glyburide; metformin hydrochloride in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glyburide; metformin hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Czechia · Glibomet
  • France · Glucovance
  • Italy · Diaglimet, Glibomet
  • Portugal · Glucovance
  • Romania · Bidiab, Glibomet
  • Slovenia · Glucovance
  • Slovakia · Glibomet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/470008b7-a283-47e2-81d7-564534f05ecf
GET /v1/drugs/470008b7-a283-47e2-81d7-564534f05ecf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2.5; 500",
  "substance": "GLYBURIDE; METFORMIN HYDROCHLORIDE",
  "productndc": "65841-825",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA206748",
  "marketing_category": "ANDA"
}

See everything about glyburide; metformin hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.